Boston Scientific Corp (BSX), while announing higher earnings in fourth quarter, but below market estimates, on Wednesday issued outlook for first quarter and fiscal 2023. The company projects higher earnings and sales for both period, while adjusted earnings would be in line or below market estimates.
from RTT - Before the Bell https://ift.tt/BtT56PO
via IFTTT
No comments:
Post a Comment